GSA Capital Partners’s Verona Pharma VRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $691K | Sell |
7,303
-13,223
| -64% | -$1.25M | 0.05% | 698 |
|
|
2025
Q1 | $1.3M | Sell |
20,526
-32,846
| -62% | -$2.09M | 0.12% | 227 |
|
|
2024
Q4 | $2.48M | Buy |
53,372
+23,859
| +81% | +$1.11M | 0.18% | 49 |
|
|
2024
Q3 | $849K | Buy |
+29,513
| New | +$849K | 0.06% | 578 |
|
|
2023
Q3 | – | Sell |
-29,432
| Closed | -$622K | – | 1942 |
|
|
2023
Q2 | $622K | Buy |
+29,432
| New | +$622K | 0.06% | 604 |
|
|
2022
Q2 | – | Sell |
-13,150
| Closed | -$66K | – | 1832 |
|
|
2022
Q1 | $66K | Buy |
+13,150
| New | +$66K | 0.01% | 1329 |
|